Literature DB >> 25650438

Enabling consistency in pluripotent stem cell-derived products for research and development and clinical applications through material standards.

Anna French1, Christopher Bravery2, James Smith3, Amit Chandra4, Peter Archibald4, Joseph D Gold5, Natalie Artzi6, Hae-Won Kim7, Richard W Barker3, Alexander Meissner8, Joseph C Wu9, Jonathan C Knowles10, David Williams4, Guillermo García-Cardeña11, Doug Sipp12, Steve Oh13, Jeanne F Loring14, Mahendra S Rao15, Brock Reeve16, Ivan Wall17, Andrew J Carr18, Kim Bure19, Glyn Stacey20, Jeffrey M Karp21, Evan Y Snyder22, David A Brindley23.   

Abstract

There is a need for physical standards (reference materials) to ensure both reproducibility and consistency in the production of somatic cell types from human pluripotent stem cell (hPSC) sources. We have outlined the need for reference materials (RMs) in relation to the unique properties and concerns surrounding hPSC-derived products and suggest in-house approaches to RM generation relevant to basic research, drug screening, and therapeutic applications. hPSCs have an unparalleled potential as a source of somatic cells for drug screening, disease modeling, and therapeutic application. Undefined variation and product variability after differentiation to the lineage or cell type of interest impede efficient translation and can obscure the evaluation of clinical safety and efficacy. Moreover, in the absence of a consistent population, data generated from in vitro studies could be unreliable and irreproducible. Efforts to devise approaches and tools that facilitate improved consistency of hPSC-derived products, both as development tools and therapeutic products, will aid translation. Standards exist in both written and physical form; however, because many unknown factors persist in the field, premature written standards could inhibit rather than promote innovation and translation. We focused on the derivation of physical standard RMs. We outline the need for RMs and assess the approaches to in-house RM generation for hPSC-derived products, a critical tool for the analysis and control of product variation that can be applied by researchers and developers. We then explore potential routes for the generation of RMs, including both cellular and noncellular materials and novel methods that might provide valuable tools to measure and account for variation. Multiparametric techniques to identify "signatures" for therapeutically relevant cell types, such as neurons and cardiomyocytes that can be derived from hPSCs, would be of significant utility, although physical RMs will be required for clinical purposes. ©AlphaMed Press.

Entities:  

Mesh:

Year:  2015        PMID: 25650438      PMCID: PMC4339854          DOI: 10.5966/sctm.2014-0233

Source DB:  PubMed          Journal:  Stem Cells Transl Med        ISSN: 2157-6564            Impact factor:   6.940


  26 in total

1.  Minimum information about a microarray experiment (MIAME)-toward standards for microarray data.

Authors:  A Brazma; P Hingamp; J Quackenbush; G Sherlock; P Spellman; C Stoeckert; J Aach; W Ansorge; C A Ball; H C Causton; T Gaasterland; P Glenisson; F C Holstege; I F Kim; V Markowitz; J C Matese; H Parkinson; A Robinson; U Sarkans; S Schulze-Kremer; J Stewart; R Taylor; J Vilo; M Vingron
Journal:  Nat Genet       Date:  2001-12       Impact factor: 38.330

2.  Differentiating embryonic stem cells: GAPDH, but neither HPRT nor beta-tubulin is suitable as an internal standard for measuring RNA levels.

Authors:  Christopher L Murphy; Julia M Polak
Journal:  Tissue Eng       Date:  2002-08

3.  The Joint Committee for Traceability in Laboratory Medicine (JCTLM): a global approach to promote the standardisation of clinical laboratory test results.

Authors:  David Armbruster; Richard R Miller
Journal:  Clin Biochem Rev       Date:  2007-08

4.  Qualification of embryonal carcinoma 2102Ep as a reference for human embryonic stem cell research.

Authors:  Richard Josephson; Carol J Ording; Ying Liu; Soojung Shin; Uma Lakshmipathy; Araz Toumadje; Bradley Love; Jonathan D Chesnut; Peter W Andrews; Mahendra S Rao; Jonathan M Auerbach
Journal:  Stem Cells       Date:  2007-02       Impact factor: 6.277

Review 5.  Guidelines and techniques for the generation of induced pluripotent stem cells.

Authors:  Nimet Maherali; Konrad Hochedlinger
Journal:  Cell Stem Cell       Date:  2008-12-04       Impact factor: 24.633

6.  Consensus guidance for banking and supply of human embryonic stem cell lines for research purposes.

Authors: 
Journal:  Stem Cell Rev Rep       Date:  2009-12       Impact factor: 5.739

Review 7.  Reference materials for cellular therapeutics.

Authors:  Christopher A Bravery; Anna French
Journal:  Cytotherapy       Date:  2014-07-22       Impact factor: 5.414

8.  Modeling human disease with pluripotent stem cells: from genome association to function.

Authors:  Florian T Merkle; Kevin Eggan
Journal:  Cell Stem Cell       Date:  2013-06-06       Impact factor: 24.633

9.  Comparison of defined culture systems for feeder cell free propagation of human embryonic stem cells.

Authors:  Veronika Akopian; Peter W Andrews; Stephen Beil; Nissim Benvenisty; Jennifer Brehm; Megan Christie; Angela Ford; Victoria Fox; Paul J Gokhale; Lyn Healy; Frida Holm; Outi Hovatta; Barbara B Knowles; Tenneille E Ludwig; Ronald D G McKay; Takamichi Miyazaki; Norio Nakatsuji; Steve K W Oh; Martin F Pera; Janet Rossant; Glyn N Stacey; Hirofumi Suemori
Journal:  In Vitro Cell Dev Biol Anim       Date:  2010-02-26       Impact factor: 2.416

10.  Importance of suitable reference gene selection for quantitative RT-PCR during ATDC5 cells chondrocyte differentiation.

Authors:  Zhichen Zhai; Yongchang Yao; Yingjun Wang
Journal:  PLoS One       Date:  2013-05-21       Impact factor: 3.240

View more
  14 in total

1.  Contractility of single cardiomyocytes differentiated from pluripotent stem cells depends on physiological shape and substrate stiffness.

Authors:  Alexandre J S Ribeiro; Yen-Sin Ang; Ji-Dong Fu; Renee N Rivas; Tamer M A Mohamed; Gadryn C Higgs; Deepak Srivastava; Beth L Pruitt
Journal:  Proc Natl Acad Sci U S A       Date:  2015-09-28       Impact factor: 11.205

Review 2.  Multiscale technologies for treatment of ischemic cardiomyopathy.

Authors:  Morteza Mahmoudi; Mikyung Yu; Vahid Serpooshan; Joseph C Wu; Robert Langer; Richard T Lee; Jeffrey M Karp; Omid C Farokhzad
Journal:  Nat Nanotechnol       Date:  2017-09-06       Impact factor: 39.213

Review 3.  Cell Replacement to Reverse Brain Aging: Challenges, Pitfalls, and Opportunities.

Authors:  Jean M Hébert; Jan Vijg
Journal:  Trends Neurosci       Date:  2018-03-13       Impact factor: 13.837

4.  Strategies for Regenerating the Lacrimal Gland.

Authors:  Catherine Y Liu; Masatoshi Hirayama; Marwan Ali; Dhara Shah; Vinay K Aakalu
Journal:  Curr Ophthalmol Rep       Date:  2017-05-29

5.  Automating Human Induced Pluripotent Stem Cell Culture and Differentiation of iPSC-Derived Retinal Pigment Epithelium for Personalized Drug Testing.

Authors:  Vincent Truong; Kevin Viken; Zhaohui Geng; Samantha Barkan; Blake Johnson; Mara C Ebeling; Sandra R Montezuma; Deborah A Ferrington; James R Dutton
Journal:  SLAS Technol       Date:  2020-12-09       Impact factor: 2.813

6.  In Pursuit of Authenticity: Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium for Clinical Applications.

Authors:  Kiyoharu J Miyagishima; Qin Wan; Barbara Corneo; Ruchi Sharma; Mostafa R Lotfi; Nathan C Boles; Fang Hua; Arvydas Maminishkis; Congxiao Zhang; Timothy Blenkinsop; Vladimir Khristov; Balendu S Jha; Omar S Memon; Sunita D'Souza; Sally Temple; Sheldon S Miller; Kapil Bharti
Journal:  Stem Cells Transl Med       Date:  2016-07-11       Impact factor: 6.940

7.  Training to Improve Precision and Accuracy in the Measurement of Fiber Morphology.

Authors:  Nathan A Hotaling; Jun Jeon; Mary Beth Wade; Derek Luong; Xavier-Lewis Palmer; Kapil Bharti; Carl G Simon
Journal:  PLoS One       Date:  2016-12-01       Impact factor: 3.240

Review 8.  A Standard Nomenclature for Referencing and Authentication of Pluripotent Stem Cells.

Authors:  Andreas Kurtz; Stefanie Seltmann; Amos Bairoch; Marie-Sophie Bittner; Kevin Bruce; Amanda Capes-Davis; Laura Clarke; Jeremy M Crook; Laurence Daheron; Johannes Dewender; Adam Faulconbridge; Wataru Fujibuchi; Alexander Gutteridge; Derek J Hei; Yong-Ou Kim; Jung-Hyun Kim; Anja Kolb- Kokocinski; Fritz Lekschas; Geoffrey P Lomax; Jeanne F Loring; Tenneille Ludwig; Nancy Mah; Tohru Matsui; Robert Müller; Helen Parkinson; Michael Sheldon; Kelly Smith; Harald Stachelscheid; Glyn Stacey; Ian Streeter; Anna Veiga; Ren-He Xu
Journal:  Stem Cell Reports       Date:  2018-01-09       Impact factor: 7.765

9.  Pluri-IQ: Quantification of Embryonic Stem Cell Pluripotency through an Image-Based Analysis Software.

Authors:  Tânia Perestrelo; Weitong Chen; Marcelo Correia; Christopher Le; Sandro Pereira; Ana S Rodrigues; Maria I Sousa; João Ramalho-Santos; Denis Wirtz
Journal:  Stem Cell Reports       Date:  2017-07-14       Impact factor: 7.765

Review 10.  Climbing the mountain: experimental design for the efficient optimization of stem cell bioprocessing.

Authors:  Derek Toms; Rob Deardon; Mark Ungrin
Journal:  J Biol Eng       Date:  2017-12-04       Impact factor: 4.355

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.